Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saracatinib in Advanced Recurrent NSCLC
NCT00638937Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2008
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saracatinib in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Feb 2008; status: completed.
02
Drugs
saracatinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00638937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638937.